Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307 Jul 26, 2018 Life Science
I-Mab Out-Licenses Bi-Specific to South Korea’s ABL Bio in $100 Million Deal Jul 26, 2018 Life Science
KEYTRUDA® (pembrolizumab) is the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma Jul 26, 2018 Life Science
Life Science & Technology Weekly 153 – Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer Jul 26, 2018 Life Science, Technology
Sunniva Inc. Unaware of Any Material Change in the Company’s Operations Jul 26, 2018 Life Science, Technology
Replicel Life Sciences Inc. (TSXV:RP) has Established a Beachhead to China’s Vast Cosmetics and Healthcare Markets – Our Talk with Lee Buckler, President and CEO, on How he was Able to Make this Happen Jul 26, 2018 Life Science, Technology
GlaxoSmithKline strikes $300 million deal with 23andMe for genetics-driven drug research Jul 25, 2018 Life Science
Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory Jul 25, 2018 Life Science
